$AGIO Company News Four signs that would indicate a new

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2015 at 11:19 AM

$AGIO Company News

Four signs that would indicate a new uptrend 2:52 p.m. Dec. 16, 2014 - The Trading Deck
Is the next Cisco out there? 3:24 p.m. Nov. 25, 2014 - The Trading Deck
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
S&P 500 returns to scene of the breakdown 9:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 10:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 6:28 a.m. April 7, 2014 - Sara Sjolin

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab 2:56 p.m. Jan. 9, 2015 - TheStreet.com
InsiderInsights.com Daily Round Up 1/6/15: XOMA, CODI, MNST, BBY 10:37 a.m. Jan. 8, 2015 - Seeking Alpha
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains 8:25 p.m. Jan. 6, 2015 - TheStreet.com
Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions 3:08 p.m. Jan. 6, 2015 - TheStreet.com
Jim Cramer: Why Are You Shorting Innovative Biotech Stocks? 11:37 a.m. Jan. 6, 2015 - TheStreet.com
Biotech Stocks 2014: The Best, Worst and Fastest-Growing 8:33 a.m. Jan. 2, 2015 - TheStreet.com
Bull of the Day: Incyte (INCY) - Bull of the Day 1:00 a.m. Jan. 2, 2015 - Zacks.com
Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens 6:00 a.m. Dec. 29, 2014 - TheStreet.com
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's "Dead Cat Bounce" Stock 9:57 a.m. Dec. 24, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO) in Focus: Stock Tanks 13.6% - Tale of the Tape 8:48 a.m. Dec. 24, 2014 - Zacks.com
Agios Pharmaceuticals (AGIO) Is Today's Water-Logged And Getting Wetter Stock 12:33 p.m. Dec. 23, 2014 - TheStreet.com
Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger? 11:21 a.m. Dec. 23, 2014 - Seeking Alpha
3 Stocks With Plunging Prices 11:00 a.m. Dec. 23, 2014 - InvestorPlace.com
InsiderInsights.com Daily Round Up 12/18/14: Agios Pharmaceuticals, Inc.,Unit Corporation, China Cord Blood Corporation, Saba Software, Inc. 10:49 a.m. Dec. 19, 2014 - Seeking Alpha
Insider Trading Alert - USCR, AGIO And CVV Traded By Insiders 10:06 a.m. Dec. 19, 2014 - TheStreet.com
Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day 1:00 a.m. Dec. 19, 2014 - Zacks.com
The Winners for Best and Worst Biotech CEOs of 2014 Are... 10:01 a.m. Dec. 18, 2014 - TheStreet.com
'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield 6:00 a.m. Dec. 18, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 12/17/14: HTZ, NAV, ENH, AIRT 4:35 a.m. Dec. 18, 2014 - Seeking Alpha

Biotechs to Follow in 2015 off Fresh Insider Moves 10:01 a.m. Jan. 6, 2015 - ACCESSWIRE
Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12 4:06 p.m. Jan. 5, 2015 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver 9:31 a.m. Dec. 16, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock 8:42 p.m. Dec. 10, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Proposed Offering of Common Stock 4:23 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors 4:02 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency 1:01 p.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016 7:31 a.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies 12:31 p.m. Dec. 7, 2014 - GlobeNewswire
Critical Alerts For Agios Pharmaceuticals, Target, Dollar General, Lululemon and Costco Released By InvestorsObserver 9:31 a.m. Nov. 20, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) 6:01 p.m. Nov. 18, 2014 - GlobeNewswire
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 7, 2014 - GlobeNewswire
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting 9:09 a.m. Nov. 6, 2014 - GlobeNewswire
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014 7:32 a.m. Oct. 27, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation 7:31 a.m. Oct. 21, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 6:30 a.m. Oct. 15, 2014 - GlobeNewswire
Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 7:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver 8:31 a.m. Sept. 29, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USD 6.8 Million for Disease R&D: GHIT's Bold Bet

GHIT Fund Pumps Millions Into Health R&D In a world plagued by infectious disease outbreaks and continual health challenges, the Global Health Innovative Technology (GHIT) Fund isn't just twiddling its thumbs—they're throwing down around $6.8 million to wrestle some of the nastiest bugs out there, like malaria and Ebola. This cash doubles down on nine risky gambles,...

Oracle's Bold Vision: Targeting $225B Revenue by 2030

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Coffee Bean Brews Up Nostalgia with Tiramisu Treats

Pouring Old Favorites: The Tiramisu Return When the aromas of coffee and nostalgia waft through the air, it's often a sign that The Coffee Bean & Tea Leaf® is brewing something special. This year, they've decided to double down on the holiday cheer by reintroducing their wildly popular Tiramisu beverage. This ain't just your run-of-the-mill coffee drink—it's a full-on...

EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

Liberty Systems Expands Operations with Major HQ Move

Hardly a yawn-worthy move, folks. Liberty Systems up and switched from Waukesha to Oconomowoc, boosting its digs to a sprawling 100,000-square-foot headquarters. It's a classic tale of growth for the Wisconsin-based company known for its on-site nitrogen generators and compressed air systems. Now, I'm telling you, they've more than doubled production capacity—that's a...

Bank Leumi Q3 Earnings Preview: Key Dates & Insights

A Closer Look at Bank Leumi's Upcoming Q3 Release Take a seat, folks. Bank Leumi’s gearing up to spill the beans on their Third Quarter 2026 earnings come November 17th. If you’re in the financial world, you might want to mark your calendar because these reports tend to shake things up. You know how these go - numbers rolling out, market responses, and plenty of...

Doximity Faces Legal Heat: 23% Stock Plunge Analyzed

Doximity's Rollercoaster: Steep Drop Amid Lawsuits Imagine watching your portfolio take a gut-wrenching plunge—and that's the rollercoaster ride Doximity investors experienced. On May 14, 2026, Doximity's stock nosedived by 23%, closing at $18.01 per share. This tumble, which marked a painful conclusion to a series of financial disappointments, has thrown the company...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Wendy's Faces Takeover Bid Amid Strategic Focus Shift

Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...

Custom Homes Shine: Florida’s Lucrative Property Move

Why Custom Homes Are Worth the Investment in Florida Ever thought about sinking some cash into Florida's real estate game? Well, building a custom home might just be your golden ticket, according to Paul H Schaefer II from Sage Homes LLC. I mean, everyone knows Florida's housing market is as spicy as a chili pepper, but custom homes seem to be the secret sauce here....